Market News

NASDAQ:PASG News

2 stories
tradingview

PASG Q2'26 Earnings: revenue estimate is 0 USD

PASG (Passage Bio, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (2.65) USD. Learn more details at PASG Financials pa…

TradingView en
StocksUS
tradingview

Lynx1 Capital Management Discloses Investment at Passage BIO with 21.0% Stake

Lynx1 Capital Management LP disclosed a 21.0% stake in Passage BIO, Inc. common stock. The firm filed a Schedule 13D on Jul. 02, 2026 after moving from a passive 13G because its ownership crossed 20%. The shift signals a more active posture as Passage BIO moves to merge with Remix Therapeutics.Inve…

TradingView en
StocksUS